Switch to:

Tekla Life Sciences Investors Net Margin %

: 99.46% (As of Sep. 2020)
View and export this data going back to . Start your Free Trial

Net margin is calculated as Net Income divided by its Revenue. Tekla Life Sciences Investors's Net Income for the six months ended in Sep. 2020 was $92.9 Mil. Tekla Life Sciences Investors's Revenue for the six months ended in Sep. 2020 was $93.4 Mil. Therefore, Tekla Life Sciences Investors's net margin for the quarter that ended in Sep. 2020 was 99.46%.

NYSE:HQL' s Net Margin % Range Over the Past 10 Years
Min: 96.12   Med: 98.69   Max: 101.64
Current: 99.17

96.12
101.64

NYSE:HQL's Net Margin % is ranked higher than
63% of the 1707 Companies
in the Asset Management industry.

( Industry Median: 93.12 vs. NYSE:HQL: 99.17 )

Tekla Life Sciences Investors Net Margin % Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Tekla Life Sciences Investors Annual Data
Sep17 Sep18 Sep19 Sep20
Net Margin % 98.20 96.12 101.64 99.17

Tekla Life Sciences Investors Semi-Annual Data
Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20
Net Margin % Premium Member Only Premium Member Only 98.82 101.50 101.81 98.29 99.46

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Tekla Life Sciences Investors Net Margin % Distribution

* The bar in red indicates where Tekla Life Sciences Investors's Net Margin % falls into.



Tekla Life Sciences Investors Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Tekla Life Sciences Investors's Net Margin for the fiscal year that ended in Sep. 2020 is calculated as

Net Margin=Net Income (A: Sep. 2020 )/Revenue (A: Sep. 2020 )
=123.053/124.083
=99.17 %

Tekla Life Sciences Investors's Net Margin for the quarter that ended in Sep. 2020 is calculated as

Net Margin=Net Income (Q: Sep. 2020 )/Revenue (Q: Sep. 2020 )
=92.861/93.367
=99.46 %

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Tekla Life Sciences Investors  (NYSE:HQL) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Tekla Life Sciences Investors Net Margin % Related Terms


Tekla Life Sciences Investors Net Margin % Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)